Drug Shortage Report for POTASS CHLOR 40MEQ 5% DEX AND 0.9% SOD CHLOR
Report ID | 168276 |
Drug Identification Number | 00786306 |
Brand name | POTASS CHLOR 40MEQ 5% DEX AND 0.9% SOD CHLOR |
Common or Proper name | POTASS CHLOR 40MEQ 5% DEX AND 0.9% SOD CHLOR |
Company Name | BAXTER CORPORATION |
Market Status | MARKETED |
Active Ingredient(s) | POTASSIUM CHLORIDE SODIUM CHLORIDE DEXTROSE |
Strength(s) | 300MG 900MG 5G |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 1000mL (2B2454X) |
ATC code | B05BB |
ATC description | I.V. SOLUTIONS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2022-09-02 |
Actual start date | 2022-09-02 |
Estimated end date | 2022-11-01 |
Actual end date | 2022-11-01 |
Shortage status | Resolved |
Updated date | 2022-11-02 |
Company comments | We have identified four alternative Baxter codes for your consideration if aligned to clinical practice: JB1674, JB1434, JB1264, and JB1984 |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 7125 MISSISSAUGA ROAD MISSISSAUGA, ONTARIO CANADA L5N 0C2 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v8 | 2022-11-02 | English | Compare |
v7 | 2022-10-28 | French | Compare |
v6 | 2022-10-28 | English | Compare |
v5 | 2022-10-06 | French | Compare |
v4 | 2022-10-06 | English | Compare |
v3 | 2022-09-03 | English | Compare |
v2 | 2022-08-31 | French | Compare |
v1 | 2022-08-31 | English | Compare |
Showing 1 to 8 of 8